These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23615021)

  • 21. [Uremic cardiomyopathy].
    Drüeke T
    Med Klin; 1981 Sep; 76(20):560-2. PubMed ID: 6212758
    [No Abstract]   [Full Text] [Related]  

  • 22. Uremic pruritus in chronic hemodialysis patients.
    Narita I; Iguchi S; Omori K; Gejyo F
    J Nephrol; 2008; 21(2):161-5. PubMed ID: 18446709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic profiling of uremic solutes in CKD patients.
    Toyohara T; Akiyama Y; Suzuki T; Takeuchi Y; Mishima E; Tanemoto M; Momose A; Toki N; Sato H; Nakayama M; Hozawa A; Tsuji I; Ito S; Soga T; Abe T
    Hypertens Res; 2010 Sep; 33(9):944-52. PubMed ID: 20613759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving concepts in the pathogenesis of uraemic cardiomyopathy.
    Wang X; Shapiro JI
    Nat Rev Nephrol; 2019 Mar; 15(3):159-175. PubMed ID: 30664681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrology: main advances in the last 40 years.
    Locatelli F; Del Vecchio L; Pozzoni P; Manzoni C
    J Nephrol; 2006; 19(1):6-11. PubMed ID: 16523419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Specific uremic cardiomyopathy.
    Zebe H; Goy W; Rauch H; Ritz E
    Nephron; 1976; 16(6):474-5. PubMed ID: 1264319
    [No Abstract]   [Full Text] [Related]  

  • 28. Almanac 2014: cardiomyopathies.
    Guttmann OP; Mohiddin SA; Elliott PM
    Heart; 2014 May; 100(10):756-64. PubMed ID: 24602853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Out of control: accelerated aging in uremia.
    Kooman JP; Broers NJ; Usvyat L; Thijssen S; van der Sande FM; Cornelis T; Levin NW; Leunissen KM; Kotanko P
    Nephrol Dial Transplant; 2013 Jan; 28(1):48-54. PubMed ID: 23139404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease and cardiovascular risk.
    Yerram P; Karuparthi PR; Hesemann L; Horst J; Whaley-Connell A
    J Am Soc Hypertens; 2007; 1(3):178-84. PubMed ID: 20409850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic optic neuropathy.
    Saini JS; Jain IS; Dhar S; Mohan K
    J Clin Neuroophthalmol; 1989 Jun; 9(2):131-3; discussion 134-5. PubMed ID: 2526159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uremic toxins in acute kidney injury.
    Herget-Rosenthal S; Glorieux G; Jankowski J; Jankowski V
    Semin Dial; 2009; 22(4):445-8. PubMed ID: 19708999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity.
    Chillon JM; Mozar A; Six I; Maizel J; Bugnicourt JM; Kamel S; Slama M; Brazier M; Massy ZA
    Ann Pharm Fr; 2009 Jul; 67(4):234-40. PubMed ID: 19596096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation disorders in uremia.
    Molino D; De Lucia D; Gaspare De Santo N
    Semin Nephrol; 2006 Jan; 26(1):46-51. PubMed ID: 16412826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
    Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic cardiomyopathy: role of circulating digitalis like substances.
    Mohmand B; Malhotra DK; Shapiro JI
    Front Biosci; 2005 Sep; 10():2036-44. PubMed ID: 15970476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.